Table 3.
Continuous cardiac monitor results, week 4
| Patiromer (n = 16) | Control (n = 14) | Overall (N = 30) | P-value | |
|---|---|---|---|---|
| PVCs (per 24 h) | 0.36 | |||
| > 1000 | 2 (12.5%) | 4 (28.6%) | 6 (20.0%) | |
| <1000, > 500 | 1 (6.3%) | 0 (0%) | 1 (3.3%) | |
| <500 | 13 (81.3%) | 9 (64.3%) | 22 (73.3%) | |
| No sustained VT | 3 (18.8%) | 2 (14.3%) | 5 (16.7%) | >0.99 |
| Atrial fibrillation | 2 (12.5%) | 1 (7.1%) | 3 (10.0%) | >0.99 |
| Bradycardia | 0 (0%) | 1 (7.1%) | 1 (3.3%) | 0.46 |
| Pause | 0 (0%) | 0 (0%) | 0 (0%) | >0.99 |
| Any arrhythmia | 5 (31.3%) | 6 (42.9%) | 11 (36.7%) | 0.71 |
| QTc max (sec) | 0.444 (0.079) | 0.422 (0.024) | 0.434 (0.059) | 0.57 |
| QTc min (sec) | 0.330 (0.052) | 0.353 (0.034) | 0.341 (0.045) | 0.12 |
PVC, premature ventricular contraction; QTc, QT interval corrected for ventricular rate; VT ventricular tachycardia.